S100A9 Promotes Glycolytic Activity in HER2-Positive Breast Cancer to Induce Immunosuppression in the Tumor Microenvironment

A total of 667 breast cancer patients were enrolled in this study. Haematoxylin and eosin staining were used to count TIN in tissues. Human breast cancer cell lines were transfected with S100A9 specific small interfering RNA.